[14] [15] In those studies, the lowest dose (600 mg) tended to be as well-tolerated as placebo, with no significant difference in adverse events compared to placebo
However, developing these products, as challenging as they often are, is only the beginning of a long journey to make the medicine available to the public via their doctor
The evidence on that is preliminary, and the STEP 9 paper doesnt make the claim
doi:10.1111/iju.13985 Persu C, Cauni V, Gutue S, Blaj I, Jinga V, Geavlete P
Las opiniones crticas pueden publicarse si proceden de una experiencia real, son respetuosas y cumplen esta poltica
This monitoring should be individualized based on the patients baseline cancer risk factors, personal medical history, and family history of malignancy